section name header

Pronunciation ⬇

sye-ME-ti-deen

Classifications ⬆ ⬇

Therapeutic Classification: antiulcer agents

Pharmacologic Classification: histamine h2 antagonists

Indications ⬆ ⬇

REMS


Action ⬆ ⬇

  • Inhibits the action of histamine at the H2-receptor site located primarily in gastric parietal cells, resulting in inhibition of gastric acid secretion.
Therapeutic effects:
  • Healing and prevention of ulcers.
  • Decreased symptoms of GERD.
  • Decreased secretion of gastric acid.

Pharmacokinetics ⬆ ⬇

Absorption: Well absorbed following oral administration.

Distribution: Well distributed to tissues.

Metabolism/Excretion: 30% metabolized by the liver; remainder is eliminated unchanged by the kidneys.

Half-Life: 2 hr.

Time/Action Profile ⬆ ⬇

ROUTEONSETPEAKDURATION
PO30 min45–90 min4–5 hr

Contraind./Precautions ⬆ ⬇

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects ⬆ ⬇

CV: ARRHYTHMIAS

Endo: gynecomastia

GI: constipation, diarrhea, hepatitis, nausea

GU: ↓sperm count, erectile dysfunction

Hemat: anemia, AGRANULOCYTOSIS, APLASTIC ANEMIA, neutropenia, thrombocytopenia

Neuro: confusion, dizziness, drowsiness, hallucinations, headache

Misc: hypersensitivity reactions

Interactions ⬆ ⬇

Drug-drug:

Drug-Natural Products:

Route/Dosage ⬆ ⬇

Renal Impairment

Availability ⬆ ⬇

(Generic available)

Assessment ⬆ ⬇

Lab Test Considerations:

Implementation ⬆ ⬇

Patient/Family Teaching ⬆ ⬇

Evaluation/Desired Outcomes ⬆ ⬇

US Brand Names ⬆ ⬇

Tagamet

Code ⬆

NDC Code